Negative surgical margins regardless of surgery type was associated with increased overall survival in patients with Merkel cell carcinoma.

Analysts have set 12-month price targets for Teleflex, revealing an average target of $153.2, a high estimate of $191.00, and ...

The company has returned 24,000% over its lifetime and has declined 20% from its high. However, investors should read this ...

Amplitude Surgical (ISIN: FR0012789667, Mnemo: AMPLI, PEA-PME eligible), the French market leader in surgical technologies for lower limb orthopedics, announces its results for the first half of the ...

As an investor, if you are uncomfortable with the risks and high valuation, there are two stocks well-positioned to be more ...

Amplitude Surgical posted a gross margin of 70.2%, down 53 bp on the first six months of the previous year, mainly due to higher product costs. Group operating expenses came to €23.1m ...

TransMedics' NOP advances organ transplantation with improved outcomes & cost reductions. See why I rate TMDX stock a strong ...

A total of 1 analyst ratings have been received for AngioDynamics, with the consensus rating being Buy. The average one-year price target stands at $15.0, suggesting a potential 59.74% upside.

As health systems face unrelenting pressure from workforce shortages, tightening financial margins, and growing patient ...